Clinical Care Options 2018 - Measurable Residual Disease in Acute Lymphoblastic Leukemia

dbrock's picture
CCO 2018 - MRD in ALL
GRACE Videos and Articles

GRACE has partnered with Clinical Care Options (CCO) Oncology, to share with our community a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).


We are thrilled to share with you video discussions with the following panel:

  • ~Elias Jabbour, MD, Associate Professor Department of Leukemia at the University of Texas MD Anderson Cancer Center in Houston, Texas
  • ~Joseph D. Khoury, MD, Professor, Department of Hematology at the University of Texas MD Anderson Cancer Center in Houston, Texas 
  • ~Aaron C. Logan, MD, Ph.D., Associate Professor Division of Hematology and Blood and Marrow Transplantation at the University of California, San Francisco

In this video series, the doctors discuss MRD in ALL.  Topics include:

Measurable Residual Disease - What Can Physicians Do with MRD Information

Measurable Residual Disease - What Does it Mean to be MRD Positive

Measurable Residual Disease - What is MRD and Why is it Important

Measurable Residual Disease - What Tests Used, How do They Work, and Which is Best for the Patient

Measurable Residual Disease - When Should they Test MRD and How do they get MRD from Patients


For more information about this video program with CCO - please visit https://www.clinicaloptions.com/oncology/programs/mrd-in-all/on-demand-v....

Video Language: 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation